Campath and Sinus tachycardia - a phase IV clinical study of FDA data

Summary:

Sinus tachycardia is reported as a side effect among people who take Campath (alemtuzumab), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Fludara, and have Chronic lymphocytic leukaemia.

The phase IV clinical study analyzes which people have Sinus tachycardia when taking Campath. It is created by eHealthMe based on reports of 4,897 people who have side effects when taking Campath from the FDA, and is updated regularly.

What is Campath?

Campath has active ingredients of alemtuzumab. eHealthMe is studying from 4,909 Campath users. Check the latest studies of Campath.

What is Sinus tachycardia?

Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node) is found to be associated with 1,267 drugs and 1,412 conditions by eHealthMe. Check the latest studies of Sinus tachycardia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 25, 2026

4,897 people reported to have side effects when taking Campath.
Among them, 17 people (0.35%) have Sinus tachycardia.

Among these 17 people:

How long have people been on Campath when they have Sinus tachycardia? *

What is the gender of people who have Sinus tachycardia when taking Campath? *

female: 41.18 %
male: 58.82 %

What is the age of people who have Sinus tachycardia when taking Campath? *

What are other drugs people take besides Campath? *

What are other side effects people have besides Sinus tachycardia? *

Leukopenia (less number of white blood cells in blood): 5 people, 29.41%
Pneumonia: 5 people, 29.41%
Urticaria (rash of round, red welts on the skin that itch intensely): 5 people, 29.41%
Thrombocytopenia (decrease of platelets in blood): 5 people, 29.41%
Pleural Effusion (water on the lungs): 4 people, 23.53%
Headache (pain in head): 4 people, 23.53%
Diarrhea: 4 people, 23.53%
Hypotension (abnormally low blood pressure): 4 people, 23.53%
Septic Shock (shock due to blood infection): 4 people, 23.53%
Weight Decreased: 3 people, 17.65%

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 6 people, 35.29%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 23.53%
Rashes (redness): 2 people, 11.76%
Headache (pain in head): 2 people, 11.76%
B-Cell Small Lymphocytic Lymphoma (blood cancer affecting b cells): 2 people, 11.76%
Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 5.88%
Peripheral T-Cell Lymphoma Unspecified (peripheral t-cell cancer unspecified): 1 person, 5.88%
Bone Marrow Conditioning Regimen: 1 person, 5.88%
Adult T-Cell Lymphoma/leukaemia Refractory (cancer of the immune system's own t-cells-resistant to treatment): 1 person, 5.88%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Campath and have Sinus tachycardia?

- Check whether Sinus tachycardia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Campath:

Campath (4,909 reports)

Browse all side effects of Campath:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinus tachycardia:

Sinus tachycardia (1,267 drugs)

Browse all the conditions that are associated with Sinus tachycardia:

Sinus tachycardia (1,412 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on alemtuzumab (the active ingredients of Campath) and Campath (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.